Our 7-Pillar Evaluation Methodology
Every clinic in our registry undergoes a rigorous 7-point audit before inclusion. Here is exactly how we evaluate and score each provider.
True Out-of-Pocket Cost Calculation (Weight: 25%)
We tally the total required expense for a 3-month and 6-month treatment course. This includes starter medication pricing, maintenance dosage escalation rates, mandatory monthly membership fees, clinician consultation fees, and mandatory shipping surcharges.
Compounding Pharmacy Sourcing & Standards (Weight: 20%)
We verify whether medications are sourced from state-licensed 503A traditional sterile compounding pharmacies or FDA-registered 503B outsourcing facilities. We reject any provider using unverified overseas suppliers or salt forms of semaglutide.
Clinician Qualifications & Medical Oversight (Weight: 15%)
We evaluate the clinical intake process. Does the provider utilize licensed US physicians (MD/DO) and nurse practitioners (NP)? Are patients screened for personal or familial history of medullary thyroid carcinoma or pancreatitis?
Cancellation & Refund Transparency (Weight: 15%)
We inspect contract terms: Can users cancel directly through their web dashboard with 1 click, or are they subjected to mandatory phone calls or 30-day notice traps? Are refunds issued if a patient is medically disqualified during physician review?
Patient Sentiment & Delivery Timelines (Weight: 10%)
We aggregate verified patient feedback from Trustpilot, Google Reviews, and dedicated Reddit forums. We track real-world refill turnaround times and customer support responsiveness.
Regulatory Standing & FDA Compliance (Weight: 10%)
We review FDA inspection reports, FDA warning letters, and state medical board sanctions. Clinics with active unaddressed safety warnings are flagged immediately.
State-by-State Availability (Weight: 5%)
Certain providers are restricted by state telehealth laws or compounding shipping boundaries (e.g. California, New York, Louisiana). We verify geographic shipping availability.